Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Clarify how the wash-sale rule applies to ETFs, including practical timing, replacement restrictions, and compliant planning.
9,454 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
The Virtus InfraCap U.S. Preferred Stock ETF (PFFA) offers a 9.5% yield, backed by 188 holdings and modest leverage. ...
When a company reports Q1 2026 results, the earnings call is where plans meet numbers. This guide explains how to rea...
Ethereum sits near $2,100 in May 2026 as the market weighs upgrades, staking growth and ETF demand. This story breaks...
PIMCO’s Multi Sector Bond Active ETF PYLD delivered a near-10% return over the past year, topping key bond indexes an...
Pension funds are aggressively loading up on the Vanguard Intermediate-Term Government Bond ETF, a move that highligh...
Bitcoin has shown extreme volatility but a history of rebound. This piece weighs the long-term case for newcomers, wi...
The (nrxp) 2026 earnings call highlights a shifting biotech landscape. This article breaks down what the results mean...
AI-powered data centers are fueling a breakout in infrastructure plays. They offer a viable alternative to chip stock...
A fresh AI-driven forecast points XRP toward a multi-dollar climb in the next 90 days, backed by a leverage-driven se...
June 2026 could redefine crypto markets as regulatory clarity and ETF adoption accelerate institutional flows. Here a...
Could buying ethereum today spark outsized gains? This article weighs a bank's bold thesis against real-world risks a...